Cargando…
The Emerging Role of m6A Modification in Endocrine Cancer
SIMPLE SUMMARY: Endocrine tumors often cause hormonal imbalances and sometimes hormone syndrome. Generally, the prognosis of patients with metastatic endocrine malignancies is poor due to recurrence and treatment failure. Aberrant expression of m6A may disrupt the development and occurrence of malig...
Autores principales: | Ji, Xiaoyu, Wang, Zhiyuan, Sun, Wei, Zhang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954123/ https://www.ncbi.nlm.nih.gov/pubmed/36831377 http://dx.doi.org/10.3390/cancers15041033 |
Ejemplares similares
-
Emerging roles of m6A RNA modification in cancer therapeutic resistance
por: Liu, Wei-Wei, et al.
Publicado: (2023) -
Emerging roles of N6-methyladenosine (m(6)A) modification in breast cancer
por: Wang, Yanyan, et al.
Publicado: (2020) -
Emerging Mutual Regulatory Roles between m(6)A Modification and microRNAs
por: Mei, Zongqin, et al.
Publicado: (2023) -
Emerging role of m6A methylation modification in ovarian cancer
por: Chang, Lin-Lin, et al.
Publicado: (2021) -
The emerging roles of m(6)A modification in liver carcinogenesis
por: Pan, Xue-yin, et al.
Publicado: (2021)